A single-center, retrospective study of pembrolizumab based therapy in metastatic non-small cell lung cancer patients with or without brain metastases
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Adenocarcinoma; Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 18 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology